These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 29166945

  • 1. Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors.
    Takakusagi Y, Saitoh JI, Kiyohara H, Oike T, Noda SE, Ohno T, Nakano T.
    Radiat Oncol; 2017 Nov 22; 12(1):185. PubMed ID: 29166945
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T, Saito K, Kiyohara H, Ohno T, Nakano T, Takagishi K.
    Radiat Oncol; 2015 Dec 21; 10():259. PubMed ID: 26691334
    [Abstract] [Full Text] [Related]

  • 4. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
    Stieb S, Snider JW, Placidi L, Kliebsch U, Lomax AJ, Schneider RA, Weber DC.
    Int J Radiat Oncol Biol Phys; 2018 Jan 01; 100(1):218-225. PubMed ID: 29029887
    [Abstract] [Full Text] [Related]

  • 5. [Present status of carbon ion radiotherapy for malignant tumors].
    Sugahara S, Kamada T.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(11):1795-800. PubMed ID: 19920380
    [Abstract] [Full Text] [Related]

  • 6. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K, Yamamoto N, Karube M, Nakajima M, Matsufuji N, Tsuji H, Ogawa K, Kamada T.
    Radiat Oncol; 2017 May 30; 12(1):91. PubMed ID: 28558766
    [Abstract] [Full Text] [Related]

  • 7. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C, Jäkel O, Karger CP.
    Radiother Oncol; 2019 Dec 30; 141():234-238. PubMed ID: 31522880
    [Abstract] [Full Text] [Related]

  • 8. Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma.
    Yanagi T, Kamada T, Tsuji H, Imai R, Serizawa I, Tsujii H.
    Radiother Oncol; 2010 Apr 30; 95(1):60-5. PubMed ID: 19767117
    [Abstract] [Full Text] [Related]

  • 9. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B, Ares C, Lomax AJ, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1432-40. PubMed ID: 22349042
    [Abstract] [Full Text] [Related]

  • 10. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y, Jin D, Sulaiman NS, Nagano F, Terashima K, Tokumaru S, Akagi T, Fujii O, Daimon T, Sasaki R, Fuwa N, Okimoto T.
    Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):367-374. PubMed ID: 28463156
    [Abstract] [Full Text] [Related]

  • 11. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X, Du Y, Wang Z, Li P, Yu Z, Zhang Q, Zhang Z.
    Radiat Oncol; 2020 Aug 28; 15(1):209. PubMed ID: 32859234
    [Abstract] [Full Text] [Related]

  • 12. Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analysis.
    Li Y, Guan X, Hu C.
    Strahlenther Onkol; 2024 Oct 28; 200(10):895-902. PubMed ID: 38926185
    [Abstract] [Full Text] [Related]

  • 13. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
    Preda L, Stoppa D, Fiore MR, Fontana G, Camisa S, Sacchi R, Ghitti M, Viselner G, Fossati P, Valvo F, Vitolo V, Bonora M, Iannalfi A, Vischioni B, Vai A, Mastella E, Baroni G, Orecchia R.
    Radiother Oncol; 2018 Aug 28; 128(2):203-208. PubMed ID: 29279241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
    Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S, Tateishi A, Working Group for the Bone and Soft Tissue Sarcomas.
    J Clin Oncol; 2002 Nov 15; 20(22):4466-71. PubMed ID: 12431970
    [Abstract] [Full Text] [Related]

  • 17. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
    Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, Kandatsu S, Kamada T, Tsuji H, Suhara T, Suzuki K, Tanada S, Tsujii H.
    Clin Cancer Res; 2004 Mar 01; 10(5):1764-72. PubMed ID: 15014030
    [Abstract] [Full Text] [Related]

  • 18. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
    Serizawa I, Kagei K, Kamada T, Imai R, Sugahara S, Okada T, Tsuji H, Ito H, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1105-10. PubMed ID: 19467578
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
    Kinoshita H, Yonemoto T, Yamada S, Imai R.
    Anticancer Res; 2024 Apr 15; 44(4):1773-1780. PubMed ID: 38537982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.